Clinical Trial Update: Anticaries Effect of Probiotic Lactobacillus Brevis CD2 (Lb CD2). [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the anticaries effect of the probiotic Lactobacillus brevis CD2 (Lb CD2) for dental caries and gingivitis. The study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Caries
• Gingivitis

Drugs mentioned

• Lb CD2 (Lactobacillus brevis CD2)

Snippet

Sponsor: Università degli Studi di Sassari | Conditions: Dental Caries, Gingivitis | Phase 4 | Status: UNKNOWN